Queen Mary University of London Spinouts vs Scala Biodesign
Queen Mary University of London Spinouts vs Scala Biodesign, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Queen Mary University of London Spinouts is on 7/100 and Scala Biodesign on 56/100.
Where each one leads
Queen Mary University of London Spinouts
- domain rating: 84/100 against 23/100
Scala Biodesign
- our overall score: 56/100 against 7/100
- agent readiness: 45/100 against 25/100
At a glance
| Measure | Queen Mary University of London Spinouts | Scala Biodesign |
|---|---|---|
| What it is | A collective of grant-stage to Series A companies spun out from Queen Mary University of London, actively seeking investment in sectors like life sciences, AI, and sustainability. | Designs proteins with superior properties using computational analysis, evolutionary insights, and AI. |
| Category | Life Sciences, Sustainability, University Spinout, Technology Transfer | Life Sciences, Biotech, Protein, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | Not published | 2021 |
| Headquarters | London, United Kingdom | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Queen Mary University of London Spinouts | Scala Biodesign |
|---|---|---|
| Employees | Not published | 30 |
| Headcount growthLast 12 months | Not published | +49.4% |
| Total funding | Not published | $21.5M |
| Latest round | Funding Round | Series A |
| Valuation | $1.1B | Not published |
| LinkedIn followers | Not published | 5,945 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Queen Mary University of London Spinouts | Scala Biodesign |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 7/100 | 56/100 |
| Traction | Not published | 52/100 |
| Team | Not published | 70/100 |
| Search visibility | Not published | 34/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (25/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 84/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Queen Mary University of London Spinouts | Scala Biodesign |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | CloudFront | Not detected |
| CMS | Not detected | Wix |
| Frameworks | Jquery, Tailwind CSS | Not detected |
| Analytics | Google Tag Manager, Linkedin Insight | Linkedin Insight |
| Open source | No | Yes |
Queen Mary University of London Spinouts vs Scala Biodesign: common questions
Which is better, Queen Mary University of London Spinouts or Scala Biodesign?
On our 0-100 score Scala Biodesign rates higher (56/100 against 7/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Queen Mary University of London Spinouts and Scala Biodesign compare on the numbers?
Queen Mary University of London Spinouts leads on domain rating (84/100 against 23/100). Scala Biodesign leads on our overall score (56/100 against 7/100), agent readiness (45/100 against 25/100).
Read the full Queen Mary University of London Spinouts review and pricing or the Scala Biodesign review and pricing. You can also browse other Queen Mary University of London Spinouts alternatives we track.